From: Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
Group
Adjuvant chemo-radiotherapy (n = 84)
Adjuvant radiotherapy (n = 67)
p value
3-year
5-year
LR
5 (6.0%)
7 (8.3%)
8 (11.9%)
10 (14.9%)
0.069
SM
6 (7.1%)
11 (16.4%)
18 (26.9%)
0.002